Zenith
Executive Summary
Generic manufacturer indicates in a Feb. 9 release that it is making progress in bringing back products recalled under a June 1986 agreement between the company and FDA. Zenith said that at present products for which supplements have not yet been approved "accounted for approximately 9% of company sales" during the first half of 1986. "The comparable figure at the time the company's quarterly report was filed in mid-November was 21% [of first half sales]," Zenith said.